| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |